A large collection of conserved eukaryotic peptidyl-prolyl cis-trans isomerases. Some members of this group are secreted (into the ER).. Localization: Cytoplasmic (by homology) / ER (by homology)
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 15 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 16 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 21 |
| NetGPI | no | yes: 0, no: 21 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 4 |
| GO:0005930 | axoneme | 2 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 6 |
| GO:0016020 | membrane | 2 | 2 |
Related structures:
AlphaFold database: E9AC11
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 22 |
| GO:0006457 | protein folding | 2 | 11 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 22 |
| GO:0008152 | metabolic process | 1 | 22 |
| GO:0009987 | cellular process | 1 | 11 |
| GO:0018193 | peptidyl-amino acid modification | 5 | 22 |
| GO:0018208 | peptidyl-proline modification | 6 | 22 |
| GO:0019538 | protein metabolic process | 3 | 22 |
| GO:0036211 | protein modification process | 4 | 22 |
| GO:0043170 | macromolecule metabolic process | 3 | 22 |
| GO:0043412 | macromolecule modification | 4 | 22 |
| GO:0044238 | primary metabolic process | 2 | 22 |
| GO:0071704 | organic substance metabolic process | 2 | 22 |
| GO:1901564 | organonitrogen compound metabolic process | 3 | 22 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 22 |
| GO:0003824 | catalytic activity | 1 | 22 |
| GO:0016853 | isomerase activity | 2 | 22 |
| GO:0016859 | cis-trans isomerase activity | 3 | 22 |
| GO:0140096 | catalytic activity, acting on a protein | 2 | 22 |
| GO:0005488 | binding | 1 | 2 |
| GO:0016018 | cyclosporin A binding | 4 | 2 |
| GO:0033218 | amide binding | 2 | 2 |
| GO:0042277 | peptide binding | 3 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 221 | 225 | PF00656 | 0.236 |
| CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.397 |
| CLV_PCSK_FUR_1 | 135 | 139 | PF00082 | 0.264 |
| CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.320 |
| CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.395 |
| CLV_PCSK_PC1ET2_1 | 137 | 139 | PF00082 | 0.294 |
| CLV_PCSK_SKI1_1 | 141 | 145 | PF00082 | 0.399 |
| CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.336 |
| CLV_PCSK_SKI1_1 | 220 | 224 | PF00082 | 0.387 |
| CLV_Separin_Metazoa | 43 | 47 | PF03568 | 0.305 |
| DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.374 |
| DEG_SPOP_SBC_1 | 271 | 275 | PF00917 | 0.193 |
| DOC_CYCLIN_yCln2_LP_2 | 12 | 18 | PF00134 | 0.228 |
| DOC_MAPK_gen_1 | 147 | 156 | PF00069 | 0.302 |
| DOC_MAPK_MEF2A_6 | 149 | 158 | PF00069 | 0.289 |
| DOC_PP1_RVXF_1 | 163 | 169 | PF00149 | 0.276 |
| DOC_PP1_RVXF_1 | 289 | 296 | PF00149 | 0.333 |
| DOC_PP2B_LxvP_1 | 42 | 45 | PF13499 | 0.305 |
| DOC_PP4_FxxP_1 | 203 | 206 | PF00568 | 0.204 |
| DOC_USP7_MATH_1 | 198 | 202 | PF00917 | 0.364 |
| DOC_USP7_MATH_1 | 271 | 275 | PF00917 | 0.193 |
| DOC_USP7_MATH_1 | 319 | 323 | PF00917 | 0.214 |
| DOC_USP7_MATH_1 | 54 | 58 | PF00917 | 0.435 |
| LIG_14-3-3_CanoR_1 | 187 | 192 | PF00244 | 0.385 |
| LIG_14-3-3_CanoR_1 | 283 | 288 | PF00244 | 0.288 |
| LIG_BIR_III_4 | 259 | 263 | PF00653 | 0.231 |
| LIG_BRCT_BRCA1_1 | 199 | 203 | PF00533 | 0.204 |
| LIG_BRCT_BRCA1_1 | 274 | 278 | PF00533 | 0.392 |
| LIG_FHA_1 | 251 | 257 | PF00498 | 0.355 |
| LIG_FHA_2 | 117 | 123 | PF00498 | 0.492 |
| LIG_FHA_2 | 219 | 225 | PF00498 | 0.277 |
| LIG_FHA_2 | 324 | 330 | PF00498 | 0.312 |
| LIG_LIR_Apic_2 | 200 | 206 | PF02991 | 0.214 |
| LIG_LIR_Apic_2 | 251 | 257 | PF02991 | 0.259 |
| LIG_LIR_Gen_1 | 169 | 177 | PF02991 | 0.315 |
| LIG_LIR_Gen_1 | 276 | 285 | PF02991 | 0.254 |
| LIG_LIR_Gen_1 | 34 | 44 | PF02991 | 0.359 |
| LIG_LIR_Nem_3 | 169 | 174 | PF02991 | 0.358 |
| LIG_LIR_Nem_3 | 216 | 222 | PF02991 | 0.221 |
| LIG_LIR_Nem_3 | 276 | 282 | PF02991 | 0.365 |
| LIG_LIR_Nem_3 | 34 | 39 | PF02991 | 0.366 |
| LIG_LIR_Nem_3 | 5 | 10 | PF02991 | 0.393 |
| LIG_PDZ_Class_1 | 330 | 335 | PF00595 | 0.386 |
| LIG_Pex14_1 | 167 | 171 | PF04695 | 0.343 |
| LIG_PTB_Apo_2 | 26 | 33 | PF02174 | 0.303 |
| LIG_PTB_Phospho_1 | 26 | 32 | PF10480 | 0.301 |
| LIG_REV1ctd_RIR_1 | 216 | 224 | PF16727 | 0.217 |
| LIG_SH2_CRK | 10 | 14 | PF00017 | 0.400 |
| LIG_SH2_CRK | 171 | 175 | PF00017 | 0.251 |
| LIG_SH2_CRK | 254 | 258 | PF00017 | 0.251 |
| LIG_SH2_CRK | 36 | 40 | PF00017 | 0.289 |
| LIG_SH2_GRB2like | 27 | 30 | PF00017 | 0.324 |
| LIG_SH2_NCK_1 | 171 | 175 | PF00017 | 0.236 |
| LIG_SH2_PTP2 | 279 | 282 | PF00017 | 0.319 |
| LIG_SH2_STAP1 | 171 | 175 | PF00017 | 0.231 |
| LIG_SH2_STAP1 | 36 | 40 | PF00017 | 0.426 |
| LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.565 |
| LIG_SH2_STAT5 | 151 | 154 | PF00017 | 0.266 |
| LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.271 |
| LIG_SH2_STAT5 | 279 | 282 | PF00017 | 0.231 |
| LIG_SH2_STAT5 | 292 | 295 | PF00017 | 0.231 |
| LIG_SH3_3 | 199 | 205 | PF00018 | 0.357 |
| LIG_TRFH_1 | 10 | 14 | PF08558 | 0.229 |
| LIG_TYR_ITSM | 6 | 13 | PF00017 | 0.388 |
| LIG_WRC_WIRS_1 | 4 | 9 | PF05994 | 0.295 |
| MOD_CK1_1 | 76 | 82 | PF00069 | 0.488 |
| MOD_CK2_1 | 69 | 75 | PF00069 | 0.523 |
| MOD_CK2_1 | 97 | 103 | PF00069 | 0.623 |
| MOD_Cter_Amidation | 135 | 138 | PF01082 | 0.279 |
| MOD_GlcNHglycan | 236 | 239 | PF01048 | 0.291 |
| MOD_GlcNHglycan | 275 | 278 | PF01048 | 0.352 |
| MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.380 |
| MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.485 |
| MOD_GSK3_1 | 193 | 200 | PF00069 | 0.375 |
| MOD_GSK3_1 | 214 | 221 | PF00069 | 0.259 |
| MOD_GSK3_1 | 230 | 237 | PF00069 | 0.385 |
| MOD_GSK3_1 | 319 | 326 | PF00069 | 0.406 |
| MOD_GSK3_1 | 69 | 76 | PF00069 | 0.745 |
| MOD_GSK3_1 | 78 | 85 | PF00069 | 0.480 |
| MOD_N-GLC_2 | 181 | 183 | PF02516 | 0.292 |
| MOD_NEK2_1 | 143 | 148 | PF00069 | 0.498 |
| MOD_NEK2_1 | 170 | 175 | PF00069 | 0.290 |
| MOD_NEK2_1 | 193 | 198 | PF00069 | 0.193 |
| MOD_NEK2_1 | 218 | 223 | PF00069 | 0.310 |
| MOD_NEK2_1 | 278 | 283 | PF00069 | 0.297 |
| MOD_NEK2_1 | 73 | 78 | PF00069 | 0.773 |
| MOD_NEK2_2 | 198 | 203 | PF00069 | 0.214 |
| MOD_NEK2_2 | 240 | 245 | PF00069 | 0.312 |
| MOD_PIKK_1 | 60 | 66 | PF00454 | 0.513 |
| MOD_PKA_2 | 186 | 192 | PF00069 | 0.399 |
| MOD_Plk_1 | 154 | 160 | PF00069 | 0.297 |
| MOD_Plk_1 | 250 | 256 | PF00069 | 0.292 |
| MOD_Plk_1 | 69 | 75 | PF00069 | 0.702 |
| MOD_Plk_4 | 109 | 115 | PF00069 | 0.374 |
| MOD_Plk_4 | 198 | 204 | PF00069 | 0.348 |
| MOD_Plk_4 | 214 | 220 | PF00069 | 0.178 |
| MOD_Plk_4 | 283 | 289 | PF00069 | 0.252 |
| MOD_Plk_4 | 319 | 325 | PF00069 | 0.305 |
| MOD_SUMO_for_1 | 40 | 43 | PF00179 | 0.485 |
| TRG_DiLeu_BaEn_1 | 103 | 108 | PF01217 | 0.392 |
| TRG_ENDOCYTIC_2 | 10 | 13 | PF00928 | 0.390 |
| TRG_ENDOCYTIC_2 | 151 | 154 | PF00928 | 0.239 |
| TRG_ENDOCYTIC_2 | 171 | 174 | PF00928 | 0.231 |
| TRG_ENDOCYTIC_2 | 279 | 282 | PF00928 | 0.232 |
| TRG_ENDOCYTIC_2 | 292 | 295 | PF00928 | 0.305 |
| TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.353 |
| TRG_Pf-PMV_PEXEL_1 | 220 | 224 | PF00026 | 0.354 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1IL84 | Leptomonas seymouri | 55% | 100% |
| A0A0S4IKA5 | Bodo saltans | 38% | 100% |
| A0A3Q8ICB3 | Leishmania donovani | 29% | 100% |
| A0A3R7M7E5 | Trypanosoma rangeli | 42% | 100% |
| A0A3S5H7U6 | Leishmania donovani | 37% | 100% |
| A0A3S7X325 | Leishmania donovani | 26% | 100% |
| A0A3S7X410 | Leishmania donovani | 31% | 97% |
| A0A3S7XB52 | Leishmania donovani | 34% | 100% |
| A0A451EJ79 | Leishmania donovani | 94% | 100% |
| A4H346 | Leishmania braziliensis | 83% | 99% |
| A4HCI8 | Leishmania braziliensis | 27% | 100% |
| A4HHU7 | Leishmania braziliensis | 24% | 100% |
| A4HIW9 | Leishmania braziliensis | 33% | 100% |
| A4HRE3 | Leishmania infantum | 94% | 100% |
| A4I004 | Leishmania infantum | 29% | 100% |
| A4I4Z7 | Leishmania infantum | 25% | 100% |
| A4I698 | Leishmania infantum | 31% | 97% |
| A4I935 | Leishmania infantum | 37% | 100% |
| A4IDA1 | Leishmania infantum | 34% | 100% |
| C9ZXF5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
| E9AJA8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
| E9AVX7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
| E9B0C7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
| E9B1F3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 98% |
| E9B400 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 100% |
| P0C1I2 | Rhizopus delemar (strain RA 99-880 / ATCC MYA-4621 / FGSC 9543 / NRRL 43880) | 30% | 100% |
| Q4Q1A6 | Leishmania major | 33% | 100% |
| Q4Q6Q9 | Leishmania major | 31% | 97% |
| Q4Q7V7 | Leishmania major | 25% | 100% |
| Q4QBK2 | Leishmania major | 29% | 100% |
| V5B9Y6 | Trypanosoma cruzi | 42% | 100% |